Cephalon, Barr End Clash Over Provigil

Law360, New York (February 2, 2006, 12:00 AM EST) -- Trying to stave off generic competition for as long as possible, Cephalon has reached another settlement over the narcolepsy drug Provigil, this time with generic drug maker Barr Pharmaceuticals Inc.

On Wednesday, Cephalon announced that it had entered into a nonexclusive licensing agreement with Barr for Provigil, only weeks after the company brokered a similar agreement with Mylan Pharmaceuticals Inc. for the sleep disorder drug.

As part of the deal, Cephalon also agreed to sweeten a pre-existing arrangement with Barr over the pain reliever drug Actiq....
To view the full article, register now.